Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Viberzi
Viberzi Image


Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Viberzi?

Viberzi is an FDA-approved prescription medication that is specifically designed to treat irritable bowel syndrome with diarrhea as the predominant symptom (IBS-D). This condition is characterized by recurrent episodes of abdominal pain or discomfort, along with changes in bowel movements, including frequent loose or watery stools. The active ingredient in Viberzi is eluxadoline, which functions by targeting receptors in the gastrointestinal system to regulate bowel function. It helps to reduce the overactivity of the bowel, leading to a decrease in symptoms such as diarrhea and abdominal pain. It's worth noting that Viberzi is not intended for use in individuals who have a history of bile duct obstruction, pancreatitis, or severe liver impairment. Like any medication, Viberzi may cause side effects, including constipation, nausea, and abdominal pain. It is crucial to follow your healthcare provider's instructions and report any adverse reactions promptly. As always, consult with your healthcare professional to determine if Viberzi is the right treatment option for your specific condition. They will be able to assess your individual needs and guide you on proper usage and potential risks associated with the medication.

How to use Viberzi?

Viberzi, also known by its generic name eluxadoline, is an FDA-approved prescription medication used to treat irritable bowel syndrome (IBS) where diarrhea is the predominant symptom, commonly known as IBS-D. It is important to follow your doctor's instructions and the medication guide provided. Viberzi comes in the form of oral tablets and is typically taken with or without food twice a day. The recommended dosage is 100 mg twice a day for most patients. However, your doctor may adjust the dosage based on your individual needs. It's essential to take Viberzi as prescribed and at the same time each day for optimal effectiveness. Do not take more or less than the recommended dose or stop taking it without consulting your doctor, as this may affect its efficacy. If you miss a dose, take it as soon as you remember, unless it is close to your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Remember to store Viberzi at room temperature, away from moisture and heat. Keep it out of the reach of children and safely discard any unused or expired medication. It's important to note that Viberzi may cause side effects such as constipation, nausea, abdominal pain, vomiting, and a risk of pancreatitis in some individuals. If you experience severe or persistent side effects, make sure to contact your healthcare provider for further guidance. Lastly, it's crucial to communicate openly with your doctor about any existing medical conditions, medications, or supplements you are taking, as they may interact with Viberzi and affect its effectiveness or cause potential harm. Your healthcare provider is there to guide you and ensure the best treatment plan for your IBS-D symptoms.

Viberzi (eluxadoline) is a medication prescribed for the treatment of irritable bowel syndrome with diarrhea (IBS-D). While it can be effective in managing symptoms, there are important warnings associated with its use that should be considered. One significant warning is the risk of pancreatitis, an inflammation of the pancreas. Cases of severe pancreatitis, including some that have resulted in death, have been reported in patients taking Viberzi. Therefore, this medication should not be used in individuals who do not have a gallbladder, as they may be at a higher risk for pancreatitis. Another important warning is for those with a history of alcohol or substance abuse. Viberzi can have effects on the central nervous system, leading to potential abuse and dependence. It is important to use this medication only as prescribed and to inform your healthcare provider if you have a history of substance abuse. Additionally, Viberzi should not be used in patients with severe liver impairment, as it may lead to serious complications. There may be other warnings associated with Viberzi that your healthcare provider can discuss with you. It is important to have an open and honest conversation with your healthcare provider about your medical history and any potential risks or side effects. They can provide guidance on whether Viberzi is the right medication for your specific situation.

Before taking Viberzi (eluxadoline), there are several important warnings and precautions to consider: 1. Pancreatitis: Viberzi can increase the risk of developing pancreatitis, a serious and potentially life-threatening inflammation of the pancreas. If you experience severe abdominal pain, persistent nausea or vomiting, or unexplained changes in your bowel movements while taking Viberzi, seek medical attention immediately. 2. Gallbladder problems: Viberzi can also lead to an increased risk of developing gallbladder problems, including gallstone formation or gallbladder inflammation. Inform your healthcare provider if you have a history of gallbladder disease or if you experience symptoms such as sudden pain in the upper right or center of the abdomen, fever, or jaundice. 3. Opioid use: Viberzi should not be used in individuals who are taking opioids due to the risk of potentially severe and life-threatening adverse reactions. This includes individuals who have recently discontinued opioid medications. Inform your doctor if you are currently using or have recently used opioids. 4. Alcohol use: It is recommended to avoid or limit alcohol consumption while on Viberzi. Combining alcohol with Viberzi may increase the risk of developing serious side effects such as liver problems. 5. Allergic reactions: If you have a known allergy or hypersensitivity to eluxadoline or any of the other ingredients in Viberzi, do not take this medication. Allergic reactions to Viberzi can manifest as rash, itching, hives, swelling of the face, lips, or tongue, or difficulty breathing. Always discuss your medical history and any other medications or supplements you are taking with your healthcare provider before starting Viberzi to ensure it is safe and appropriate for you.

Viberzi, also known by its generic name eluxadoline, is a prescription medication approved by the FDA to treat irritable bowel syndrome with diarrhea as the predominant symptom (IBS-D). While Viberzi can be effective in managing IBS-D, like any medication, it may also come with potential side effects. Common side-effects of Viberzi include constipation, nausea, and abdominal pain. These symptoms may occur in some individuals but typically resolve on their own without intervention. However, it's important to be aware of more serious side effects that can occur in rare cases. These include pancreatitis, which is inflammation of the pancreas, and sphincter of Oddi spasm, which causes abdominal pain. If you experience persistent or severe abdominal pain, you should seek medical attention promptly. It's crucial to note that Viberzi has been associated with an increased risk of pancreatitis in individuals without a gallbladder. Therefore, it should not be used in this population. As always, it's vital to discuss any concerns or potential side effects with your healthcare provider. They can provide personalized advice and guidance based on your individual medical history.

The active ingredient in Viberzi is eluxadoline. Eluxadoline is a synthetic compound that binds to certain receptors in the digestive system, known as mu-opioid receptors, and also acts as a kappa-opioid receptor agonist. By interacting with these receptors, Viberzi helps to regulate the functions of the gastrointestinal tract and reduce the symptoms of irritable bowel syndrome with diarrhea (IBS-D). In addition to eluxadoline, Viberzi contains other inactive ingredients or excipients, which are substances that are added to the medication to facilitate its manufacturing, stability, or absorption. However, the specific inactive ingredients may vary between different brands or formulations of the drug. It's important to remember that Viberzi should be taken only as prescribed by a healthcare professional. As with any medication, it is crucial to follow the recommended dosage and instructions for use to ensure safety and effectiveness.

Store Viberzi (eluxadoline) in a safe and secure place, away from moisture and heat. Keep it at room temperature, ideally between 68°F and 77°F (20°C and 25°C). Make sure to store it out of reach of children and pets to avoid any accidental ingestion. The medication should be kept in its original packaging or container to protect it from light and moisture. Avoid transferring the tablets to a different container unless instructed by a healthcare professional. If you have any unused or expired Viberzi tablets, it's important to dispose of them properly. Do not flush them down the toilet or throw them in the trash, as they could harm the environment or be accidentally consumed. Instead, consult with a pharmacist or local waste disposal facility on the proper method of medication disposal in your area. Always check the expiration date on the packaging before using Viberzi. If the medication has expired, it should be safely discarded and not consumed.